Table 1 Demographic and clinical history of patients that qualified for the survival analysis
Demographics | Patients evaluable at baseline | Patients evaluable at 12-week treatment follow-up |
|---|---|---|
(N = 80) | (N = 62) | |
Median (range) | ||
Age | 71 (54–84) | 71 (54–84) |
PSA at diagnosis | 46 (3.7–4625) | 46 (3.7–1018) |
Primary treatment | N (%) | |
Radiation therapy | 22 (28) | 19 (30) |
Radical prostatectomy | 13 (16) | 9 (15) |
Prior systemic treatment | ||
Prior ADT | 80 (100) | 62 (100) |
Prior chemo | 64 (80) | 47 (75) |
Covariates | Median (range) | |
PSA (ng/mL) | 157.5 (1.1–5460) | 149 (1.1–5460) |
ALP (U/L) | 124.3 (41.2–1058) | – |
HgB (mmol/L) | 7.5 (5.2–10.0) | – |
BSI | 2.7 (0.01–21.11) | 2.6 (0.01–21.11) |
N (%) | ||
Deaths | 56 (70) | 40 (65) |